Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation

Abstract

MMX-budesonide tablets appear suitable for targeted colonic drug delivery. Transit parameters and low systemic bioavailability warrant further studies with the new formulation.